NYSE · NL

NLI Holdings, Inc.

$5.78 -$0.03 (-0.52%) 1D Market open

Key Metrics

$284.10M
Market cap
P/E · TTM
$158.58M
Revenue · TTM
−$34.15M
Net income
EPS · TTM $-0.70
Dividend yield 6.4%
Free cash flow $4.20M
Beta · 1Y 0.76
EBITDA · TTM −$42.58M
Gross margin 31.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 22
    From its May 27 high, the share price fell 34%.

    Peak close $8.52 on May 27; trough close $5.64 on Jul 22. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 29
    The stock moved -17.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 29
  • May 15
    The stock moved +14.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 15

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$284.10M
Enterprise value
Shares outstanding48.9M
52-wk range$5.04 – $8.60
Avg volume · 20D33.3K
Net cash
Book value / share$7.36
IndustryIndustrial Inorganic Chemicals
ExchangeNYSE
About NLI Holdings, Inc.
IPO dateDec 23, 1988
Employees2263

NLI Holdings Inc, formerly known as NL Industries Inc, is a holding company that operates in the component products industry.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S1.79
P/FCF67.63
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 31.1%
Operating -29.1%
Net -21.5%
FCF 2.6%
ROE / ROIC -9.0% · -12.3%

Financial Health

Current ratio10.65
Quick ratio8.60
Debt / equity
Debt / EBITDA
Net cash
Working capital$141.23M

Cash Flow · TTM

Operating CF $7.53M
Capex −$3.33M
Free cash flow $4.20M
Buybacks
Dividends paid $18.09M
Shareholder yield 6.4%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings